Structure-function studies of FR-1: A growth factor-inducible aldo-keto reductase

Advances in Experimental Medicine and Biology

Volumn 463, Issue , 1999, Pages 435-443

  Petrash, J M ^a   Harter, T M ^a   Srivastava, S ^a   Chandra, A ^a   Bhatnagar, A ^a   Srivastava, S K ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; GROWTH FACTOR;

CONFERENCE PAPER; ENZYME ANALYSIS; ENZYME INACTIVATION; ENZYME INDUCTION; ENZYME KINETICS; ENZYME PURIFICATION; ENZYME STRUCTURE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ANALYSIS;

EID: 0033282768     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4735-8_54     Document Type: Conference Paper

References (26)

1. Cytoplasmic Aldo-Keto Reductases: A Class of Drug Metabolizing Enzymes
2. Mechanism of Human Aldehyde Reductase. Characterization of the Active Site Pocket
3. The crystal structure of the aldose reductase.NADPH binary complex
4. Identification and Characterization of a Novel Human Aldose Reductase-like Gene
5. Site-specific inactivation of aldose reductase by 4-hydroxynonenal
6. A delayed-early gene activated by fibroblast growth factor-encodes a protein related to aldose reductase
7. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
8. Human aldose reductase - Rate constants for a mechanism including interconversion of ternary complexes by recombinant wild-type enzyme
9. Human aldose reductase - Subtle effects revealed by rapid kinetic studies of the c298a mutant enzyme
10. Immunoquantitation of aldose reductase in human tissues
11. Differential control of murine aldose reductase and fibroblast growth factor (FGF)-regulated-1 gene expression in NIH 3T3 cells by FGF-1 treatment and hyperosmotic stress
12. Cloning, sequencing, and enzymatic activity of an inducible aldo-keto reductase from Chinese hamster ovary cells
13. Cellular Detoxification of Tripeptidyl Aldehydes by an Aldo-keto Reductase
14. Tissue-specific expression of two aldose reductase-like genes in mice: Abundant expression of mouse vas deferens protein and fibroblast growth factor-regulated protein in the adrenal gland
15. Expression and aggregation of recombinant alpha A-crystallin and its two domains
16. Novel, potent aldose reductase inhibitors: 3,4-dihydro-oxo-3- [[5-(trifluoromethyl)-2-benzothiazolyl] methyl]- 1- phthalazineacetic acid (zopolrestat) and congeners
17. Overexpression and mutagenesis of the cDNA for rat liver 3 alpha- hydroxysteroid/dihydrodiol dehydrogenase. Role of cysteines and tyrosines in catalysis
18. Involvement of cysteine residues in catalysis and inhibition of human aldose reductase - Site-directed mutagenesis of cys-80, cys-298, and cys-303
19. Mutagenesis of 3 alpha-hydroxysteroid dehydrogenase reveals a "push-pull" mechanism for proton transfer in aldo-keto reductases
20. New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma
21. Identification of cardiac oxidoreductase(s) involved in the metabolism of the lipid peroxidation-derived aldehyde-4-hydroxynonenal
22. Probing the active site of human aldose reductase. Site-directed mutagenesis of Asp-43, Tyr-48, Lys-77, and His-100
23. An unlikely sugar substrate site in the 1.65 A structure of the human aldose reductase holoenzyme implicated in diabetic complications
24. 1.7 A structure of FR-1, a fibroblast growth factor-induced member of the aldo-keto reductase family, complexed with coenzyme and inhibitor
25. Refined 1.8 A structure of human aldose reductase complexed with the potent inhibitor zopolrestat
26. Biological interactions of alpha,beta-unsaturated aldehydes